Introduction
Key Teaching Points
•
Ventricular arrhythmias originating from the left ventricular summit and intramyocardially
within the interventricular septum pose a serious challenge to catheter ablation,
as myocardial thickness, epicardial fat, and coronary vessels impede appropriate radiofrequency
energy delivery.
•
Intracoronary mapping and subsequent intramyocardial ablation using radiofrequency
ablation delivered through a system routinely used to treat coronary artery chronic
total occlusions (ie, Stingray LP Coronary CTO Re-Entry System) is feasible and effective.
•
Unlike alcohol injection and coil embolization of septal perforator arteries, intramyocardial
RF ablation using this technique is a more localized and limited approach with less
risk of complete atrioventricular block and less myocardial injury.
Ventricular arrhythmias (VA) originating from the left ventricular (LV) summit and
intramyocardially within the interventricular septum pose a serious challenge to catheter
ablation (CA), as myocardial thickness, epicardial fat, and coronary vessels impede
appropriate radiofrequency (RF) energy delivery to the target areas. Several strategies
have been proposed to effectively eliminate these VA.1, 2, 3, 4, 5 Nonetheless, each
of these is associated with a series of limitations and potential complications, and
until now no consensus exists on the optimal ablation strategy for VA originating
from these anatomic sites. We describe a novel technique of intracoronary mapping
and subsequent intramyocardial ablation using RF ablation delivered through a system
routinely used to treat coronary artery chronic total occlusions (ie, Stingray LP
Coronary CTO Re-Entry System, Boston Scientific, Marlborough, MA).
Case report
A 48-year-old man with a previous history of nonischemic cardiomyopathy based on a
left ventricular ejection fraction (LVEF) of 25% and normal coronary arteries was
evaluated in our institution for frequent symptomatic premature ventricular contractions
(PVCs) that had been diagnosed 5 years earlier (PVC burden of 35%, n = 43,000). Cardiac
magnetic resonance imaging with gadolinium did not reveal myocardial delayed enhancement
and fluorine-18 deoxyglucose positron emission tomography–computed tomography (18F-FDG
PET-CT) ruled out active cardiac sarcoidosis. The initial 12-lead electrocardiogram
(ECG) showed a PVC with left bundle branch block morphology and inferior axis with
early transition in lead V2. The PVC had a maximum deflection index > 0.55, pseudodelta
wave > 34 ms, and intrinsicoid deflection time > 85 ms. These features suggested an
epicardial origin in the LV outflow tract (ie, LV summit) (Figure 1A and B). Two previous
ablation attempts performed in outside facilities were unsuccessful: the initial CA
procedure was undertaken within the coronary sinus (CS), with an earliest site of
activation found at the great cardiac vein (GCV) / anterior interventricular vein
(AIV) junction. Nonetheless, RF delivery was limited by high impedance measured at
the catheter tip. The second procedure used an epicardial approach, but despite 25
minutes of total RF time, the PVC could not be eliminated, most likely because of
thick epicardial fat. Owing to persistent symptoms, impaired LVEF, and high PVC burden
despite medical treatment with high-dose beta blockers (ie, metoprolol 200 mg daily),
the patient was referred for a third attempt at our arrhythmia center.
Figure 1
A: Standard 12-lead electrocardiogram (ECG) (paper speed 25 mm/s) showing premature
ventricular contraction (PVC) with left bundle branch block morphology and inferior
axis with early transition in precordial leads (ie, lead V2). Notice the very positive
deflection in inferior leads and the QS complexes in leads aVR and aVL. All these
finding suggest a left ventricular outflow tract (LVOT) origin. B: A 12-lead ECG (paper
speed 100 mm/s) demonstrating similar PVC morphology except for an earlier transition
in precordial leads owing to slightly different lead placement during ablation procedure.
Maximum deflection index (0.57), pseudodelta wave 63 ms, and intrinsicoid deflection
time of 97 ms are all suggestive of an LVOT epicardial origin (LV summit). However,
an aVL/aVR Q ratio < 1.6 (patients’ aVL/aVR Q ratio was 1.2) and an R-wave ratio III/II
< 1.4 (patients’ R-wave ratio III/II was 1.1) are predictive of an origin in the inaccessible
area of the LV summit.
During initial electrophysiology study, right ventricular and LV mapping was performed
with a 3.5-mm Navistar Thermocool DF mapping ablation catheter (Biosense-Webster,
Diamond Bar, CA). The right ventricular outflow tract, sinuses of Valsalva, and the
aortomitral continuity were mapped with an earliest activation point observed in the
left coronary cusp (−2 ms). Subsequently, the mapping catheter was advanced into the
coronary sinus (CS) demonstrating earlier activation times at the GCV/AIV junction
(−22 ms) and in the AIV (−24 ms), with a perfect pace map in this last location (12/12)
(Figure 2). Coronary angiogram was performed prior to ablating, revealing close proximity
between the ablation catheter tip and the proximal left anterior descending (LAD)
coronary artery (Figure 2). Consequently, RF ablation from the CS was avoided. Since
the patient had previously undergone a failed epicardial ablation, and taking into
consideration that the 12-lead ECG revealed a PVC with an aVL/aVR Q ratio < 1.6 (patients’
aVL/aVR Q ratio was 1.2) and an R-wave ratio III/II < 1.4 (patients’ R-wave ratio
III/II was 1.1), which indicated that the PVC origin was in the inaccessible area
of the LV summit, epicardial access was not performed.
Figure 2
A: Electroanatomic mapping showing earliest site of activation at the great cardiac
vein/anterior interventricular vein junction. B, C: Angiographic images in (B) left
anterior oblique and (C) right anterior oblique projections depicting the relation
between the ablation catheter tip and the proximal left anterior descending artery
(LAD). Noticeably, the earliest activation found within the anterior interventricular
vein (marked by the tip of the ablation catheter) is clearly in close proximity with
the first septal perforator branch (*). D: A perfect pace map (12/12 leads) was achieved
in this site. E: Activation mapping of the clinical premature ventricular contraction
in the CS showing earliest site of activation (red) at the anterior interventricular
vein (−24 ms pre-QRS). ABL = ablation catheter; CS = coronary sinus; His = His bundle;
RV = right ventricle.
Interestingly, coronary angiography also revealed that the earliest site of activation
was close to the first septal perforator artery (Figure 2). Intracoronary mapping
and potential ablation using alcohol injection or coil embolization of the septal
perforating artery was considered. A 0.014-in Vision guidewire (Biotronik SE&CO KG,
Berlin, Germany) was advanced into the first septal perforator and a confirmed early
activation at −24 ms was found. Given the large caliber of the first septal perforator
and the potential extensive myocardial damage if this were completely occluded, a
smaller more proximal septal branch was selected for coil embolization. However, the
PVC could not be eliminated with this approach. Subsequently, the intracoronary mapping
guidewire was then repositioned in the first septal perforator, and a Stingray LP
device (Boston Scientific, Marlborough, MA) (Supplemental Figure 1) was advanced into
the proximal portion of this branch (Figure 3A). Briefly, this device has a self-orienting
balloon with 180° opposed and offsetting exit ports, enabling selective guidewire
re-entry during chronic total occlusion recanalization. Although it is not designed
for electrophysiology use, we believe its self-orienting balloon provides adequate
support to allow driving the guidewire from the coronary arteries into the myocardium.
The balloon also has 2 radiopaque marker bands to facilitate accurate placement and
positioning (Figure 3B) and a hydrophilic stiff guidewire specifically designed to
perforate the arterial wall. Using the hydrophilic coated Stingray guidewire (0.014
inches/0.36 mm), the artery was deliberately perforated and the Stingray guidewire
advanced deep into the interventricular septal myocardium (Figure 3C), using orthogonal
projections in the left anterior oblique and right anterior oblique views to guide
proper guidewire position. At this first intramyocardial location, an early site of
−28 ms was obtained (Figure 3D). Subsequently, we repositioned the Stingray LP device
(Boston Scientific, Marlborough, MA) deeper into the first septal perforator where
the Stingray guidewire was again advanced into the myocardium (Figure 4). An early
activation site (−59 ms) was found at this position (Figure 5A–D). RF ablation was
undertaken through the Stingray guidewire by placing the proximal end of the guidewire
in a saline bath along with an 8-mm-tip catheter to deliver RF (power 50 W, impedance
drop 15 ohms) for a total of 2 minutes, achieving complete elimination of the PVCs
(Supplemental Figure 2). Coronary angiogram after RF ablation showed patency of the
first septal perforator (Figure 5D). No early complications occurred, and the patient
was discharged the next day. Delayed enhancement after RF ablation is depicted in
short and longitudinal axes in the interventricular septum on cardiac magnetic resonance
imaging (Figure 6) the following day after ablation. At 12-month follow-up, the patient
has had a significant improvement in his symptoms, with a marked reduction in his
PVC burden from 35% to 2% and normalization in his LVEF (ie, 60%), consistent with
PVC-induced cardiomyopathy.
Figure 3
A: A 0.014-inch Vision guidewire (Biotronik SE&CO KG, Berlin, Germany) was advanced
into the first septal perforator, over which the Stingray LP system balloon (Boston
Scientific, Marlborough, MA) was advanced. B: Radiopaque marks (seen near the tip
of the ablation catheter) are used to guide balloon placement. C: Once the Stingray
balloon was in place, the Vision guidewire was removed, and the Stingray guidewire
was advanced into the myocardium. D: Earliest activation in this initial intramyocardial
location was −28 ms.
Figure 4
Illustration depicting ablation technique using the Stingray CTO system. A Stingray
balloon was advanced into the first septal perforator, and a hydrophilic Stingray
guidewire was used to perforate the arterial wall and advanced into the interventricular
myocardium. The proximal end of the wire was then introduced into a saline bath along
with the ablation catheter, and radiofrequency was delivered in this way, achieving
successful premature ventricular contraction ablation. LAD = left anterior descending
artery; LCC = left coronary cusp; LCx = left circumflex artery; LV = left ventricle;
RCA = right coronary artery; RCC = right coronary cusp.
Figure 5
Final position of the Stingray system. A, B: The balloon is positioned deep into the
first septal perforator (A), and the Stingray wire has been advanced deeper into the
myocardium (B). C: An early activation site (−59 ms) was found, and ablation using
a nonirrigated 8-mm catheter dipped in a saline bath alongside the guidewire was undertaken.
D: After ablation, repeat coronary angiogram shows patency of the first septal perforator,
limiting the amount of myocardium suffering damage to the target area.
Figure 6
Cardiac magnetic resonance imaging performed before the ablation (A–C) and the following
day after ablation (D–F). No scar can be seen at baseline, and after ablation delayed
enhancement (representing myocardial lesion formation; red arrows, panels D–F) can
be observed in the anterior basal septum and left ventricular summit.
Discussion
Although highly effective in eliminating PVCs, CA of VA is limited by the origins’
anatomic location even when using a combined endo-epicardial approach. VA originating
from the LV summit and mid myocardium (particularly in the interventricular septum)
are difficult to map and ablate, owing to limited access and difficulties in delivering
long-lasting lesions. Additionally, RF ablation for LV summit VAs is still challenging
even when performing RF ablation from the CS or the epicardial space, because of the
close proximity with the coronary arteries, a thick epicardial fat pad, and frequent
intramural sites of origin (Supplemental Figure 3). The LV summit is defined as the
region on the epicardial LV surface near the bifurcation of the left main coronary
artery bounded by the LAD superior to the first septal perforating branch and anterior
to the left circumflex artery laterally. The GCV bisects the LV summit into a superior
portion (the inaccessible area) and an inferior portion (the accessible area). It
is important to understand that the interventricular septum and the LV summit are
thick structures measuring up to 2 cm in thickness (Figure 4). Since a previous ablation
attempt had failed in this patient (even after using long-duration RF ablation with
high-power settings) and the 12-lead ECG aVL/aVR Q-wave and III/II R-wave ratios suggested
a PVC origin from the inaccessible area in the LV summit,
6
epicardial access was not attempted. Additionally, epicardial mapping and ablation
has been questioned, given the lack of additional benefit and a higher complication
rate compared with an ablation approach from within the coronary venous system and
surrounding structures. An epicardial PVC site of origin has a lower success rate,
trends toward a higher procedural complication rate, and has an increased rate of
PVC-induced cardiomyopathy.
7
Application of RF energy within the coronary venous system also raises concern for
thermal injury to the vein itself or to the neighboring coronary arteries, and isolated
reports have documented the risk of venostenosis, vein rupture or thrombosis, and
even acute coronary occlusion.
Different approaches to the elimination of intramural and LV summit PVCs have been
described, including sequential or simultaneous irrigated unipolar RF applications
delivered from the endocardium and epicardium, use of bipolar ablation, and surgical
cryoablation.1, 2, 3 In our patient, these techniques could not have been used owing
to the inability to deliver epicardial or bipolar RF ablation because of close proximity
of LAD and, in the case of bipolar ablation, a possible impedance mismatch between
the aortomitral continuity and GCV/AIV as the higher impedance of either electrode,
which would limit the current. Even surgical cryoablation has shown risk of coronary
injury, requiring percutaneous intervention to the LAD coronary artery in up to 25%
of cases.
3
This is owing to the fact that the layer of epicardial fat in the LV summit near the
trifurcation of the left main coronary artery into the LAD, ramus intermedius, and
left circumflex artery has to be dissected to obtain clear visualization of the epicardial
surface of the myocardium and to deliver cryoablation lesions in areas adjacent to
the LAD.
Alternatively, prolonged high-power ablation from the endocardium may be used to create
a deeper lesion targeting remote locations across the myocardial wall. Nevertheless,
even though irrigated catheters deliver higher power to create larger RF ablation
lesions, lesion depth is currently an important limitation when facing VA originating
in the LV summit and intraventricular septum. A study by Simmers and colleagues
8
in an animal model demonstrated that the average distance reached by a nonirrigated
4-mm-tip ablation catheter was 7.1 ± 2.6 mm and that this distance is already reached
by 10–20 seconds and that does not increase with extended duration in RF ablation
delivery. Irrigated catheters have shown to increase RF lesion size to 9–13 mm, mostly
depending on the RF ablation duration.9, 10 Consequently, RF ablation of an intramural
or LV summit VA from only 1 site is usually not enough to suppress the arrhythmia
permanently, since this anatomic structure is extremely thick (Figure 4). In some
cases, the arrhythmia might be transiently suppressed owing to tissue inflammation
but not owing to irreversible tissue injury.11, 12 Animal models have also suggested
that the use of half-normal saline or dextrose water 5% can be used to create deeper
lesions than those created with normal saline as irrigant solution, but these findings
have not been tested in humans.
13
Coil embolization and ethanol ablation have also been described extensively in prior
reports to treat patients with intramural or LV summit VAs.4, 5 However, extensive
myocardial damage and complete heart block may occur, as the extent of myocardial
injury is determined by a highly variable coronary anatomy. With a purely intramyocardial
ablation such as the one described in this case, a more limited myocardial injury
may be expected when compared to coil embolization and alcohol injection, which might
minimize any further reduction in myocardial performance and reduce the risk of lesion
to the conduction system. Although new technologies such as intramyocardial infusion-needle
CA have been performed to control refractory VAs using a temperature-controlled mode,
with promising results,
14
delivering this needle from the epicardium (in the case of intramural or LV summit
arrhythmias) will have same risks of epicardial ablation.
Although intramural recordings of electrograms and ablation using an irrigated needle-tipped
catheter have been studied for over a decade, demonstrating feasibility, to the best
of our knowledge this is the first report using direct intramuscular RF ablation through
a coronary artery branch using the Stingray device and delivering RF through a guidewire
inserted into the myocardium to eliminate arrhythmias originating deep in the mid
myocardium/LV summit. The Stingray device has a self-orienting balloon with 180° opposed
and offsetting exit ports, enabling selective guidewire re-entry into the coronary
artery lumen, and is intended to be used for treatment of chronic total coronary obstructions
(Supplemental Figure 1). This balloon provides adequate support to achieve introduction
of the guidewire (ie, Stingray wire) deep within the myocardium. Our case report provides
unique evidence of a novel technique to achieve ablation of intramural/LV summit foci.
We believe that even though applicability of this technique is highly dependent on
the anatomy of the coronary artery supplying the myocardium of interest, since the
guidewire can be advanced deeply into the myocardium, variations in coronary artery
anatomy may have a smaller impact on this technique than on alcohol or coil embolization.
Several potential complications can occur during RF application using this technique,
including coronary artery occlusion (owing to RF damage or mechanical trauma during
Stingray catheter manipulation to the endothelium) and intramural hematoma or coronary
artery–cameral fistula. Although intramural hematoma has been described in up to 7%
of patients undergoing recanalization of chronic total occlusions,
15
we believe this is probably related to the use of guidewires, microcatheters, and
balloons that are advanced subintimally through long distances, thus increasing the
risk of vascular lesion and hematoma formation. In our case, we believe this risk
is extremely small, as the guidewire is not advanced subintimally but instead is driven
directly into the myocardium.
Conclusion
Ablation of LV summit/intramural arrhythmias is technically difficult and carries
a lower success rate owing to increased tissue thickness, limited catheter maneuverability,
and proximity of coronary arteries. We present a novel technique to achieve suppression
of challenging VA using intramyocardial RF ablation, which could potentially allow
targeting areas in close proximity of coronary arteries, including the interventricular
septum and the inaccessible LV summit. Further studies are needed to confirm the safety
and efficacy of this technique.